MENTAL HEALTH MANAGEMENT INC /VA/
10-Q, 1996-05-15
GENERAL MEDICAL & SURGICAL HOSPITALS, NEC
Previous: COLEMAN HOLDINGS INC, 10-Q, 1996-05-15
Next: AFFINITY GROUP INC, 10-Q, 1996-05-15



<PAGE>


                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C.  20549
                        _________________________________

                                    FORM 10-Q


       QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
                              EXCHANGE ACT OF 1934

                 For the quarterly period ended:  MARCH 31, 1996
                         Commission File Number: 1-12238


                         MENTAL HEALTH MANAGEMENT, INC.
             (Exact name of registrant as specified in its charter)



                     DELAWARE                               52-1223048
          (State or other jurisdiction of                (I.R.S. Employer
          incorporation or organization)                Identification No.)



         7601 LEWINSVILLE ROAD, SUITE 200
                 MCLEAN, VIRGINIA                              22102
     (Address of principal executive offices)               (Zip Code)



       Registrant's telephone number, including area code:  (703) 749-4600



Indicate by check mark whether the registrant: (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days.         Yes  X    No
                                                      ---      ---

As of May 9, 1996, there were 3,310,448 shares of Common Stock, par value $.01
per share, outstanding.
<PAGE>

                         MENTAL HEALTH MANAGEMENT, INC.
                                AND SUBSIDIARIES
                          QUARTER ENDED MARCH 31, 1996

                                      INDEX

                                                                            Page
                                                                          Number
                                                                          ------

PART I.  FINANCIAL INFORMATION:

  ITEM 1.  FINANCIAL STATEMENTS.

     Condensed Consolidated Statements of Operations-
     Three and Six Months Ended March 31, 1996 and 1995
     (Unaudited)                                                             4

     Condensed Consolidated Balance Sheets-
     March 31, 1996 (Unaudited) and September 30, 1995                       5

     Condensed Consolidated Statements of Cash Flows-
     Six Months Ended March 31, 1996 and 1995
     (Unaudited)                                                             6

     Notes to Condensed Consolidated Financial
     Statements (Unaudited)                                                7-8

  ITEM 2.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF
             FINANCIAL CONDITION AND RESULTS OF OPERATIONS.               9-13



PART II.  OTHER INFORMATION                                                 14

  ITEM 6.  EXHIBITS AND REPORTS ON FORM 8-K                                 18


                                        2
<PAGE>

                         MENTAL HEALTH MANAGEMENT, INC.
                                AND SUBSIDIARIES
                          QUARTER ENDED MARCH 31, 1996







                          PART I. FINANCIAL INFORMATION

                          ITEM 1. FINANCIAL STATEMENTS


                                        3
<PAGE>

                         MENTAL HEALTH MANAGEMENT, INC.
                                AND SUBSIDIARIES

                 CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
                                   (UNAUDITED)


<TABLE>
<CAPTION>

                                                        Three Months Ended March 31,             Six Months Ended March 31,
                                                      -------------------------------         -------------------------------
                                                          1996                1995                1996                1995
                                                      -----------         -----------         -----------         -----------
<S>                                                   <C>                 <C>                 <C>                 <C>

Net revenues                                          $11,321,000         $10,390,000         $22,502,000         $20,331,000

Costs and expenses:
  Operating                                             8,108,000           7,416,000          15,919,000          14,442,000
  General and administrative                            2,867,000           2,712,000           5,631,000           4,994,000
  Provision for bad debts                               1,531,000             968,000           2,846,000           1,470,000
  Depreciation and amortization                           311,000             404,000             714,000             822,000
Other (credits) charges:
  Equity in earnings of Joint Venture                       --               (382,000)              --               (835,000)
  Gain on sale of investment
   in Joint Venture                                         --             (3,529,000)              --             (3,529,000)
  Loss on sale of facilities                            4,352,000               --              4,352,000                  --
  Interest expense - MEDIQ                                279,000             297,000             572,000             574,000
  Interest expense - other                                 98,000             131,000             194,000             295,000
  Other                                                   (17,000)            (89,000)            (54,000)            (80,000)
                                                      -----------         -----------         -----------          ----------


Income (loss) before income taxes                      (6,208,000)          2,462,000          (7,672,000)          2,178,000

Income tax expense (benefit)                                --              2,611,000            (175,000)          2,543,000
                                                      -----------         -----------         -----------          ----------

Net loss                                              $(6,208,000)        $  (149,000)        $(7,497,000)         $ (365,000)
                                                      -----------         -----------         -----------          ----------
                                                      -----------         -----------         -----------          ----------

Net loss per share                                    $     (1.88)        $      (.04)        $     (2.27)         $     (.11)
                                                      -----------         -----------         -----------          ----------
                                                      -----------         -----------         -----------          ----------

Weighted average shares outstanding                     3,310,000           3,310,000           3,310,000           3,310,000
                                                      -----------         -----------         -----------          ----------
                                                      -----------         -----------         -----------          ----------

</TABLE>


            See Notes to Condensed Consolidated Financial Statements


                                        4
<PAGE>

                         MENTAL HEALTH MANAGEMENT, INC.
                                AND SUBSIDIARIES

                      CONDENSED CONSOLIDATED BALANCE SHEETS

                                                   March 31,    September 30,
                                                     1996           1995
                                                 -----------    ------------
                                                  (Unaudited)    (See Note)
                                     ASSETS
Current Assets:
  Cash and cash equivalents                      $ 1,116,000    $ 3,084,000
  Accounts receivable, net                         7,616,000      7,618,000
  Prepaid expenses                                   245,000        397,000
  Other current assets                               611,000        976,000
                                                 -----------    -----------
     Total current assets                          9,588,000     12,075,000

Assets held for sale, net                         10,147,000             --
Property, plant and equipment, net                   621,000     12,581,000
Goodwill, net                                      1,596,000      4,519,000
Notes receivable                                   1,480,000             --
Other assets                                       1,802,000      1,108,000
                                                 -----------    -----------

Total assets                                     $25,234,000    $30,283,000
                                                 -----------    -----------
                                                 -----------    -----------


                      LIABILITIES AND STOCKHOLDERS' EQUITY

Current liabilities:
  Accounts payable                               $ 2,407,000    $ 1,672,000
  Accrued expenses                                 3,128,000      2,342,000
  Accrued expenses - sale of facilities            1,520,000             --
  Accrued payroll                                    551,000        542,000
  Accrued expenses - MEDIQ                           386,000        377,000
  Current maturities of long-term debt             1,269,000      1,219,000
                                                 -----------    -----------
     Total current liabilities                     9,261,000      6,152,000

Long-term debt, less current maturities:
  MEDIQ                                           10,350,000     10,733,000
  Other                                            2,298,000      2,422,000

Other liabilities                                     27,000        181,000

Stockholders' equity                               3,298,000     10,795,000
                                                 -----------    -----------

Total liabilities and stockholders' equity       $25,234,000    $30,283,000
                                                 -----------    -----------
                                                 -----------    -----------

Note:     The balance sheet at September 30, 1995 has been condensed from the
          audited financial statements at that date.


            See Notes to Condensed Consolidated Financial Statements


                                        5
<PAGE>

                         MENTAL HEALTH MANAGEMENT, INC.
                                AND SUBSIDIARIES

                 CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
                                   (UNAUDITED)

<TABLE>
<CAPTION>

                                                                                                 Six Months Ended March 31,
                                                                                                 --------------------------
                                                                                                  1996                1995
                                                                                                  ----                ----
<S>                                                                                           <C>                 <C>

CASH FLOWS FROM OPERATING ACTIVITIES:

Net loss                                                                                      $(7,497,000)        $  (365,000)

Adjustments to reconcile net loss to net cash
  provided by (used in) operating activities                                                    6,849,000            (372,000)
                                                                                              -----------         -----------

Net cash used in operating activities                                                            (648,000)           (737,000)

CASH FLOWS FROM INVESTING ACTIVITIES:

Capital expenditures for property,plant and equipment                                            (150,000)           (340,000)
Proceeds from sale of Joint Venture                                                                 --              9,609,000
Distributions from Joint Venture                                                                    --              1,000,000
Acquisition of clinic operations                                                                 (150,000)                 --
Other                                                                                            (223,000)            (42,000)
                                                                                              -----------         -----------

Net cash provided by (used in) investing activities                                              (523,000)         10,227,000

CASH FLOWS FROM FINANCING ACTIVITIES:

Debt repayments                                                                                  (797,000)         (6,171,000)
                                                                                              -----------         ------------

Net cash provided by (used in)
 financing activities                                                                            (797,000)         (6,171,000)
                                                                                              -----------         -----------

Increase (decrease) in cash                                                                    (1,968,000)          3,319,000

Cash and cash equivalents:
  Beginning balance                                                                             3,084,000             735,000
                                                                                              -----------         -----------

  Ending balance                                                                              $ 1,116,000         $ 4,054,000
                                                                                              -----------         -----------
                                                                                              -----------         -----------

Supplemental disclosure of cash flow information:
  Interest paid                                                                               $   766,000         $   910,000
                                                                                              -----------         -----------
                                                                                              -----------         -----------

  Income taxes (refunded) paid                                                                $  (752,000)        $  (842,000)
                                                                                              -----------         -----------
                                                                                              -----------         -----------

Supplemental disclosure of non-cash investing and
  financing activities:
  Acquisition financed with long-term debt                                                     $  338,000                  --
                                                                                              -----------         -----------
                                                                                              -----------         -----------
  Equipment financed with debt and capital leases                                              $   63,000                  --
                                                                                              -----------         -----------
                                                                                              -----------         -----------
  Notes received from sale of fixed assets                                                     $1,400,000                  --
                                                                                              -----------         -----------
                                                                                              -----------         -----------

</TABLE>


            See Notes to Condensed Consolidated Financial Statements


                                        6 
<PAGE>

                         MENTAL HEALTH MANAGEMENT, INC.
                                AND SUBSIDIARIES

              NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
                                   (UNAUDITED)


NOTE 1 - CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

The condensed consolidated balance sheet as of March 31, 1996, the condensed
consolidated statements of operations for the three and six month periods ended
March 31, 1996 and 1995 and the condensed consolidated statements of cash flows
for the six month periods then ended have been prepared by the Company, without
audit.  In the opinion of management, all adjustments (consisting only of
normal, recurring adjustments) necessary to present fairly the condensed
consolidated financial position, results of operations and cash flows as of
March 31, 1996, and for all periods presented, have been made.

Certain information and footnote disclosures normally included in financial
statements prepared in accordance with generally accepted accounting principles
have been condensed or omitted.  These condensed consolidated financial
statements should be read in conjunction with the consolidated financial
statements and notes thereto included in the Company's September 30, 1995 Annual
Report on Form 10-K.  The results of operations for the period ended March 31,
1996 are not necessarily indicative of the operating results for the full year.

RECLASSIFICATIONS - Certain items in the consolidated statement of operations
for the prior quarter have been reclassified to conform to current period
presentation.

NOTE 2 - LIQUIDITY

The accompanying consolidated financial statements have been prepared on a 
going concern basis which contemplates the continuation of operations, 
realization of assets and liquidation of liabilities in the ordinary course 
of business.  As a result of the Company's continued negative operating 
results, as well as reduced collections of accounts receivable, the Company 
has been experiencing difficulty generating sufficient cash flows to meet its 
obligations and sustain its operations.  The report of the Company's independent
auditors on the Company's financial statements for the fiscal year ended 
September 30, 1995 includes an explanatory paragraph which states that such
conditions raise substantial doubt as to the Company's ability to continue as a
going concern.  The financial statements do not include any adjustments that 
might result should the Company be unable to continue as a going concern.

Based upon the adverse impact on the Company's operating results of cost-
reduction pressures on inpatient care and the Company's belief that such
pressures would likely continue to have an adverse impact on future results, the
Company has focused its strategy on pursuing opportunities to grow its Extended
Care Services Division.  As a result, the Company is pursuing opportunities to
sell its freestanding behavioral health facilities.  The operations of the
freestanding facilities represented 74% and 87% of net revenues for the first
six months of 1996 and fiscal year 1995, respectively.  The Company is also
taking steps to reduce operating expenses, attempting to raise additional
capital, and working to improve cash flows. See Note 3.


                                        7
<PAGE>

                         MENTAL HEALTH MANAGEMENT, INC.
                                AND SUBSIDIARIES

              NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
                                   (UNAUDITED)


NOTE 3 - SALE OF FREESTANDING FACILITIES

On April 5, 1996, the Company sold Oakview Treatment Center to a non-profit
corporation affiliated with a privately-owned operator of two psychiatric
hospitals for $50,000 in cash and $2,150,000, evidenced by two promissory notes
payable to the Company.  For financial statement purposes, the notes were
recorded at an estimated net realizable value of $1,400,000.  The notes are
payable in monthly installments of principal and interest (at prime) based on 15
year amortization, with the remaining principal due in five years (or earlier
under certain circumstances).  In connection with obtaining consent to the sale
of Oakview Treatment Center as required under the terms of the Company's
revolving credit facility, the Company pledged both of the notes receivable
relating to the sale of Oakview Treatment Center as collateral for the Company's
obligations under the revolving credit facility.  In connection with obtaining a
waiver from MEDIQ of an event of default provision of the MEDIQ Note relating to
the sale of the assets of a significant subsidiary, the Company pledged one of
the notes receivable (with a principal balance of $ 1,875,000) as collateral for
the Company's obligations under the MEDIQ Note.  Upon completion of the Proposed
Sale and repayment of the revolving credit facility, the pledges under the
revolving credit facility will terminate, but the pledge under the MEDIQ Note
will continue.

The Company executed an agreement, dated as of January 24, 1996, and amended as
of April 11, 1996, (the "Agreement") to sell (the "Proposed Sale") five of the
Company's freestanding facilities (Aspen Hill Hospital, Pacific Shores Hospital,
Pinon Hills Residential Treatment Center and Windsor Hospital) (the "Hospitals")
to a privately-owned operator of nine psychiatric facilities for $10,000,000
(plus an amount representing the value at closing of certain inventory and
prepaid expenses, which was approximately $232,000 as of March 31, 1996),
consisting of approximately $8,910,000 in cash and the assumption of certain
specified liabilities of the Hospitals in the aggregate amount of approximately
$1,322,000 (estimated based upon the Company's financial condition as of March
31, 1996), as determined pursuant to the Agreement.  The actual amount of cash
to be received by the Company will be calculated upon closing based upon the
value of certain specified assets and the amount of certain specified
liabilities, as determined in accordance with the terms of the Agreement.  The
completion of the transaction is subject to several contingencies.  At a
special meeting of the stockholders held on May 13, 1996, the Proposed Sale was
approved by the holders of a majority of the Company's outstanding shares of
common stock.  The closing on the Proposed Sale has been scheduled for May 31,
1996.

The pretax loss on the sale of facilities consists of the write off of 
intangibles related to the Hospitals of $3,184,000, a loss on the sale of 
certain property, plant equipment aggregating $221,000, transaction expenses 
of $515,000, severance expenses of $330,000 and other expenses of 
$736,000 and additional expenses incurred in connection with the sale of 
Oakview Treatment Center of $26,000, offset by estimated Medicare 
depreciation recapture income.  Assets being sold have been reclassified as 
assets held for sale on the balance sheet as of March 31, 1996.

NOTE 4 - ACQUISITION OF CLINIC OPERATIONS


                                        8
<PAGE>

In December 1995, the Company's Extended Care Services Division acquired the
behavioral healthcare clinic operations of National Mentor, Inc. located in
Charlestown, Taunton and New Bedford, Massachusetts.  The purchase price
included cash of $150,000 and $338,000 payable in 36 monthly installments.



                         MENTAL HEALTH MANAGEMENT, INC.
                                AND SUBSIDIARIES

              NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
                                   (UNAUDITED)

NOTE 5 - JOINT VENTURE

Effective August 1, 1994, the Company formed a joint venture ("Joint Venture")
to combine its contract management business with that of Horizon Mental Health
Services, Inc. ("Horizon") of Denton, Texas.  The Joint Venture, which was owned
27.5% by the Company and 72.5% by Horizon, managed both companies' hospital
behavioral health care contracts.  The operating results of the contract
management business were included in the Company's results of operations through
the commencement of the Joint Venture on August 1, 1994.

On March 20, 1995, Horizon completed its initial public offering, and, in
accordance with the terms of the Joint Venture Agreement, acquired the Company's
interest in the Joint Venture for approximately $9,600,000 (net of related
expenses).  The sale resulted in a gain of approximately $500,000 (net of income
taxes of $3,000,000).  In connection with the sale, the Company assigned to
Horizon all of its rights and interests in its management contracts.


NOTE 6 - LONG-TERM DEBT

In March 1995, the Company utilized a portion of the proceeds from the sale of
its investment in the Joint Venture to repay the $5,102,000 outstanding
principal balance of a revolving credit facility, which was scheduled to mature
on March 31, 1995.  This facility was not renewed.

On August 14, 1995, the Company entered into a $5,000,000 revolving credit 
facility with a commercial lender.  The facility bears interest at the prime 
rate plus 2% (10.25% at March 31, 1996), is secured by accounts receivable 
from the freestanding facilities and property, plant and equipment at two of 
the freestanding facilities, and expires in August 1997.  At March 31, 1996, 
$1,436,000 was outstanding under this facility.  The amount of available 
credit fluctuates based upon the amount of qualified accounts receivable.  
Based upon management's analysis of accounts receivable, approximately 
$1,950,000 of credit was available at March 31, 1996.  Under the terms of 
this facility, the Company is not permitted to declare or pay any dividends.  
As of March 31, 1996, the Company did not comply with certain financial 
ratios required by the facility, particularly the minimum net worth 
requirement and working capital ratio. Subsequent to March 31, 1996, the 
Company obtained the necessary amendment from the lender. Under the terms of 
the revolving credit facility, the Company will be required to repay the 
outstanding balance, and the facility will terminate, in connection with the 
sale of the freestanding facilities.

                                        9
<PAGE>

ITEM 2.   MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
          RESULTS OF OPERATIONS

     The following discussion addresses the financial condition of the Company
as of March 31, 1996 and the Company's results of operations for the three and
six month periods then ended, compared with the same period last year.  This
discussion should be read in conjunction with the Management's Discussion and
Analysis section (pages 17-27) for the fiscal year ended September 30, 1995
included in the Company's Annual Report on Form 10-K.

GENERAL

     In response to continuing changes in the behavioral healthcare industry,
the Company made significant changes in its operations in 1994 and 1995,
including the divestiture of the Company's contract management business, so that
the Company could focus on its two remaining businesses -- its freestanding
behavioral healthcare facilities and its Extended Care Services Division (which
commenced operations in the fall of 1993).  The Extended Care Services Division
has experienced growth through internal development (principally from a contract
with the State of Georgia) and acquisitions in July and December 1995.

     However, continued pressures from managed care providers and other third
party payors to decrease the utilization and cost of behavioral healthcare
services have adversely affected the operations of the Company's freestanding
facilities, resulting in decreased revenues and significant operating losses.
As a result, the Company determined in the fourth quarter of fiscal 1995, based
upon historical operating losses and the Company's analysis of future estimated
operating results and undiscounted cash flows, that the recoverability of
certain assets, including property, plant and equipment and goodwill, related to
one of the freestanding facilities was impaired, other than temporarily.
Accordingly, the carrying value of such assets was reduced to estimated fair
value, resulting in a charge of $2,228,000.

     As a result of the Company's continued negative operating results, as 
well as reduced collections of accounts receivable, the Company has been 
experiencing difficulty generating sufficient cash flows to meet its 
obligations and sustain its operations.  The report of the Company's 
independent auditors on the Company's financial statements for the fiscal 
year ended September 30, 1995 includes an explanatory paragraph which states 
that such conditions raise substantial doubt as to the Company's ability to 
continue as a going concern.  The financial statements do not include any 
adjustments that might result from the outcome of this uncertainty.

RECENT DEVELOPMENTS

     Based upon the adverse impact on the Company's operating results of 
cost-reduction pressures on in-patient care and the Company's belief that 
such pressures would likely continue to have an adverse impact on future 
results, the Company has decided to pursue a strategy focused on growing its 
Extended Care Services Division.  As a result, the Company is pursuing 
opportunities to sell its freestanding behavioral health facilities.  In 1995 
and the first six months of fiscal 1996, the operations of the freestanding 
facilities represented 87% and 74% of net revenues, respectively.

     On April 5, 1996, the Company sold Oakview Treatment Center to a non-profit
corporation affiliated with a privately-owned operator of two psychiatric
hospitals for $50,000 in cash and $2,150,000, evidenced by two promissory notes
payable to the Company.  For financial statement purposes, the notes were
recorded at an estimated net realizable value of $1,400,000.  The notes are
payable in monthly installments of principal and interest (at prime) based on a
15 year amortization, with the remaining principal due in five years (or earlier
under certain circumstances).  In connection with obtaining consent to the sale
of Oakview Treatment Center as required under the terms of the Company's
revolving credit facility, the Company pledged both of the notes receivable
relating to the sale of Oakview Treatment Center as collateral for the Company's
obligations under the revolving credit facility.  In connection with obtaining a
waiver from MEDIQ of an event of default provision of the MEDIQ Note relating to
the sale of the assets of a significant subsidiary, the Company pledged one of
the notes receivable (with a principal balance of $1,875,000) as collateral for
the Company's obligations under the MEDIQ Note.  Upon completion of the Proposed
Sale and repayment of the revolving credit facility, the pledges under the
revolving credit facility will terminate, but the pledge under the MEDIQ Note
will continue.  See "Liquidity and Capital Resources."

     The Company executed an agreement, dated as of January 24, 1996,  (the
"Agreement") to sell (the "Proposed Sale") five of the Company's freestanding
facilities (Aspen Hill Hospital, Pacific Shores Hospital, Pinon Hills Hospital,
Pinon Hills Residential Treatment Center and Windsor Hospital) (the "Hospitals")
to a privately-owned operator of nine psychiatric facilities for $10,000,000,
plus an amount representing substantially all of the Company's working capital
investment in these facilities on the


                                       10
<PAGE>

closing of the transaction, in cash at closing.  On April 11, 1996, the Company
executed an amendment to the Agreement.  As amended, the Agreement provides for
the following changes in the structure: (i) the Company will retain all of the
accounts receivables related to the Hospitals and (ii) the cash to be paid to
the Company at Closing is to be determined by subtracting from the sum of (a)
$10,000,000 (b) the value of certain inventory and the value of certain prepaid
expenses (which was approximately $232,000 as of March 31, 1996) an amount equal
to (a) the Company's liability for paid days off accrued for employees of the
freestanding facilities who become employees of the purchaser, and (b) the value
of certain other current liabilities, accounts payable, salaries payable and
payroll taxes payable (which aggregated approximately $1,322,000 as of March 31,
1996), to be determined as of March 31, 1996, subject to adjustment following
the closing.  Based on March 31, 1996 financial information, the Company
estimates that it will receive approximately $8,910,000 in cash at closing.  The
Agreement, as amended, also provides for certain Medicare depreciation recapture
amounts to be allocated between the Company (85%) and the purchaser (15%).  Such
recapture amounts relate to potential adjustments for prior years to reflect the
loss on the sale of the Hospitals as a retroactive increase in the Company's
depreciation expense for purposes of cost-based reimbursements.  The Company
estimates that its share of the amounts to be collected pursuant to such
Medicare recapture will be approximately $1,320,000 and that it will receive
such payments beginning in two to three years after the closing.  The Agreement,
as amended, also provides for the creation of an escrow of approximately
$300,000 of the cash proceeds received by the Company for the purpose of funding
the Company's obligation to complete certain repairs to two of the Hospitals.
The completion of the transaction is subject to several contingencies.  At a
special meeting of the stockholders held on May 13, 1996, the Proposed Sale was
approved by the holders of a majority of the Company's outstanding shares of
common stock.  The closing on the Proposed Sale has been scheduled for May 31,
1996.  See "Liquidity and Capital Resources."

     The Company has not entered into any definitive agreement to sell its other
freestanding facility.  Also, the Company has not yet satisfied certain
conditions to the consummation of the Proposed Sale.  Accordingly, there can be
no assurance that the Company will be successful in selling any of such
facilities.


                                       11
<PAGE>


     The Company's freestanding facilities represent the majority of the
Company's historical business.  Overall, the freestanding facilities generated
87% and 74% of the Company's net revenues in the fiscal year ended September 30,
1995 and the first six months of fiscal year 1996, respectively.  The Company's
freestanding facilities have contributed significantly to the Company's cash
flows.  In addition, the freestanding facilities helped to absorb certain
corporate-related expenses that, following the sale of the Company's
freestanding facilities, will have to be borne fully by the Extended Care
Services Division.  Since its founding in October 1993, the Extended Care
Services Division has generated 13% and 3% of net revenues for the years ended
September 30, 1995 and 1994, respectively, and 26% of net revenues for the first
six months of fiscal 1996.  The rapid expansion of the Extended Care Services
Division has also resulted in increased costs, and thus, with the allocation of
corporate overhead related to the operations of the Extended Care Services
Division, the Extended Care Services Division has not yet achieved profitable
results.  No assurances can be given that the Company will be successful in
generating profits from the Extended Care Services Division, or that the
strategy of focusing on growing the Extended Care Services Division through
internal expansion and acquisition will not result in further increased costs.
In furtherance of such strategy, the Company completed two acquisitions in 1995
(described below), routinely reviews potential acquisition candidates, and is
negotiating letters of intent with respect to several additional acquisitions
and pursuing other acquisition and management opportunities.  The Company plans
to continue its expansion into the practice management business, which is the
thrust of the Company's long-term growth strategy, by acquiring additional
practices and/or securing long-term management agreements with additional
practices.  To date, however, the Company has not entered into definitive
agreements with respect to other acquisitions, and there can be no assurances
that any acquisitions will be completed or management opportunities will be
secured.  In addition, based upon the Company's limited liquidity and capital
resources, there can be no assurance that the Company will have sufficient
resources to pursue and/or complete any other acquisitions.  In the event the
Company needs to use the remainder of the proceeds to repay the amounts
outstanding under the MEDIQ Note as described below, the Company's plans to
expand the Extended Care Services Division would be extremely restricted, and
the Company's results of operations and financial condition may be adversely
affected.


ACQUISITION OF SUPPORTIVE COUNSELING CARE

     In July 1995, the Company's Extended Care Services Division acquired
certain assets of Supportive Counseling Care ("SCC") of Manhattan Beach,
California, a provider of behavioral healthcare services to extended care
facilities, and entered into a 40-year management contract to provide
administrative services to SCC.  The operating results related to these assets
are included in the Company's consolidated results of operations from the date
of acquisition.


ACQUISITION OF CLINIC OPERATIONS

     In December 1995, the Company's Extended Care Services Division acquired
the behavioral healthcare clinic operations of National Mentor, Inc. located in
Charlestown, Taunton, and New Bedford, Massachusetts.  The operating results of
the acquired business are included in the Company's consolidated results of
operations from the date of acquisition.


                                       12
<PAGE>

RESULTS OF OPERATIONS

     The following table sets forth for the periods indicated the percentage
relationship that items in the Company's Statements of Operations bear to net
revenues.

                                       Three Months Ended     Six Months Ended
                                            March 31,             March 31,
                                       ------------------    ------------------
                                         1996      1995      1996      1995
                                         ----      ----      ----      ----

Net revenues                              100%      100%      100%      100%

Costs and expenses:
  Operating                                72        71        71        71
  General and administrative               25        26        25        25
  Provision for bad debts                  14         9        13         7
  Depreciation and amortization             3         4         3         4
Other (credits) charges:
  Equity in earnings of Joint Venture      --        (4)       --        (4)
  Gain on Sale of Joint Venture            --       (34)       --       (17)
  Loss on sale of facilities               38        --        19        --
  Interest expense - MEDIQ                  2         3         2         3
  Interest expense - other                  1         1         1         1
  Other                                    --        --        --        --
                                          ---       ---       ---       ---
Income (loss) before income taxes         (55%)      24       (34)       11
Income tax expense (benefit)               --        25        (1)       13
                                          ---       ---       ---       ---
Net loss                                  (55%)      (1)%     (33)%      (2)%
                                          ---       ---       ---       ---
                                          ---       ---       ---       ---

SECOND QUARTER 1996 COMPARED TO SECOND QUARTER 1995

     Net revenues for the second quarter of 1996 were $11,321,000, as compared
to $10,390,000 for the prior year quarter, an increase of $1,102,000, or 11%,
reflecting an increase in revenues from the Extended Care Services Division,
partially offset by decreased revenues from the freestanding facilities.  Net
revenues from freestanding facilities were $8,159,000 in the second quarter of
1996, a decrease of $1,014,000, or 11%, as compared to the prior year quarter.
The decrease in revenues resulted from lower average reimbursement rates and
decreases in inpatient average lengths of stay.  Revenues from the Extended Care
Services Division were $3,162,000 for the second quarter of 1996, as compared to
$1,046,000 in the prior year quarter.  This increase is the result of revenues
under a contract with the state of Georgia to provide mental health services to
Medicaid patients in nursing homes and revenues of $1,774,000 attributable to
acquisitions [in July and December 1975.]

     Operating expenses for the second quarter of 1996 were $8,108,000 as
compared to $7,416,000 in the prior year quarter.  This increase was primarily
attributable to increased costs associated with growth of the Extended Care
Services Division.  As a percentage of net revenues, operating expenses were
comparable to the prior year quarter.


                                       13
<PAGE>

     General and administrative expenses were $2,867,000, or 25% of net
revenues, as compared to $2,712,000, or 26% of net revenues, in the prior year
quarter.  This increase was attributable to increased costs associated with
growth of the Extended Care Services Division offset by decreased costs 
related to the freestanding facilities.

     The provision for bad debts increased to $1,531,000 as compared to $968,000
in the prior year quarter.  As a percentage of net revenues, bad debt expense
was 14%, as compared to 9% in the prior year quarter.  The increase in the
provision for bad debts resulted primarily from the operations of SCC (acquired
in July 1995) which are subject to Medicare reimbursement limits, with the
remaining charges billed to the patients or other third party payors.

     Depreciation and amortization expense was $311,000 as compared to $404,000
in the prior year quarter.  The decrease in depreciation expense was
attributable to the sale of Oakview Treatment Center.

     The pretax loss on the sale of facilities consists of the write off of 
intangibles related to the Hospitals of $3,184,000, a loss on the sale of 
certain property, plant equipment aggregating $221,000, transaction expenses 
of $515,000, severance expenses of $330,000 and other expenses of 
$736,000 and additional expenses incurred in connection with the sale of Oakview
Treatment Center of $26,000, offset by estimated Medicare depreciation 
recapture income.

     Interest expense was $377,000, as compared to $428,000 in the prior year
quarter, primarily attributable to decreases in outstanding borrowings.

     Pretax loss for the second quarter of 1996 was $6,208,000, as compared 
to pretax income of $2,462,000 in the prior year quarter.  The prior period 
included significant non-recurring income related to the Joint Venture, 
including equity in the earnings of $382,000 and a pretax gain on the sale of 
$3,529,000.  Operating results from the Company's primary business were 
adversely affected in the current period by lower average reimbursement rates 
and decreases in inpatient average lengths of stay for the freestanding 
facilities as a result of managed care and other market forces.  Management 
expects operating results to continue to be adversely affected by these 
market forces.

SIX MONTHS ENDED MARCH 31, 1996 COMPARED TO SIX MONTHS ENDED MARCH 31, 1995

     Net revenues were $22,502,000, as compared to $20,331,000 for the prior
year period, an increase of $2,951,000, or 15%.  Net revenues from freestanding
facilities decreased $1,024,000 or 6% to $16,670,000.  The decrease in revenues
resulted from lower average reimbursement rates and decreases in inpatient
average lengths of stay.  Revenues from the Extended Care Services Division were
$5,832,000 for the first six months of 1996, as compared to $1,857,000 in the
prior year period.  This increase is the result of revenues under a contract
with the state of Georgia to provide mental health services to Medicaid patients
in nursing homes and revenues of $3,233,000 attributable to acquisitions 
in July and December 1995.

     Operating expenses were $15,919,000, as compared to $14,442,000 in the
prior year period.  This increase was primarily attributable to increased costs
associated with growth of the Extended Care


                                       14
<PAGE>

Services Division. As a percentage of net revenues, operating expenses were
comparable to the prior year period.

     General and administrative expenses were $5,631,000, as compared to
$4,994,000 in the prior year period.  This increase was attributable to
increased costs associated with growth of the Extended Care Services 
Division, offset by decreased costs related to the freestanding facilities.

     The provision for bad debts was $2,846,000.  As a percentage of net
revenues, bad debt expense was 13%, as compared to 7% in the prior year period.
The increase in the provision for bad debts resulted primarily from the
operations of SCC (acquired in July 1995) which are subject to Medicare
reimbursement limits, with the remaining charges billed to the patients or other
third party payors.

     Depreciation and amortization expense was $714,000, as compared to $822,000
in the prior year  period. The decrease in depreciation expense was attributable
to the sale of Oakview Treatment Center.

     The pretax loss on the sale of facilities consists of the write off of 
intangibles related to the Hospitals of $3,184,000, a loss on the sale of 
certain property, plant equipment aggregating $221,000, transaction expenses 
of $515,000, severance expenses of $330,000 and other expenses of 
$736,000 and additional expenses incurred in connection with the sale of Oakview
Treatment Center of $26,000, offset by estimated Medicare depreciation 
recapture income.

     Interest expense was $766,000, a decrease of $103,000 from the prior year
period, primarily attributable to decreases in outstanding borrowings.

     Pretax loss for the six month period ended March 31, 1996 increased to 
$7,672,000, as compared to pre-tax income of $2,178,000 in 1995.  The prior 
period included significant non-recurring income related to the Joint 
Venture, including equity in the earnings of $382,000 and a pretax gain on 
the sale of $3,529,000.  Operating results from the Company's primary 
business were adversely affected in the current period by lower average 
reimbursement rates and decreases in inpatient average lengths of stay for 
the freestanding facilities as a result of managed care and other market 
forces.  Management expects operating results to continue to be adversely 
affected by these market forces.


INCOME TAXES

     The Company's effective tax rates for the three and six month periods ended
March 31, 1995 were disproportionate to the statutory tax rate primarily as a
result of permanent differences related to the disposition of the Company's
interest in the Joint Venture.  The tax benefit for 1996 was adversely impacted
by limitations on the amount of net operating losses which can be carried back
to prior years.


                                       15
<PAGE>

LIQUIDITY AND CAPITAL RESOURCES

     Cash used in operating activities was $648,000 for the second quarter of
1996, as compared to $737,000 for the prior year quarter.

     Cash used in investing activities for the second quarter of 1996 
included $150,000 for capital expenditures and $150,000 for the acquisition 
of clinic operations in Massachusetts.  The Company anticipates capital 
expenditures of approximately $650,000 during the remainder of 1996.  In the 
event the proposed sales of the Company's freestanding facilities are 
consummated, and the remaining freestanding facility is sold, capital 
expenditures with respect to the freestanding facilities would be 
significantly reduced.  The Company plans to use a portion of the proceeds 
from the proposed sales to continue its expansion of the Extended Care 
Services Division.  However, based upon the Company's liquidity and capital 
resources, there can be no assurance the Company will have sufficient 
resources to expand this division.  See "Recent Developments."  Non-cash 
investing activities also included notes received in connection with the sale 
of Oakview Treatment Center recorded at net estimated realizable value of 
$1,400,000.

     Net cash used by financing activities for the second quarter of 1996
consisted of debt repayments of $797,000.  Non-cash financing activities
included a $338,000 term loan incurred in connection with the acquisition of
clinic operations in Massachusetts, payable in 36 monthly installments.

     As of March 31, 1996, the Company had $1,436,000 outstanding under a
$5,000,000 revolving credit facility.  This facility bears interest at prime
plus 2%, is secured by accounts receivable from the freestanding facilities and
property, plant and equipment of two of the freestanding facilities and expires
in August 1997.  The amount of available credit fluctuates based upon the amount
of qualified accounts receivable.  As of May 9, 1996, $2,810,000 was outstanding
under this facility.   Based upon management's analysis of accounts receivable,
approximately $50,000 of credit was available at May 9, 1996.  Under the terms
of the revolving credit facility, the Company will be required to repay the
outstanding balance, and the facility will terminate, in connection with the
sale of the freestanding facilities.

     As of March 31, 1996 the Company had $11,117,000 outstanding under its 
note payable to MEDIQ (the "MEDIQ Note").  The note bears interest at prime 
plus 1.5% per annum, with monthly payments of principal and interest, based 
on a fifteen year amortization period, with the remaining balance due in 
August 1998.  The MEDIQ Note may be prepaid in whole or in part without 
penalty.  The Company does not anticipate that cash flows from operations 
will be sufficient to repay such debt upon maturity in 1998.  In addition, as 
reflected in the financial statements of the Company, and the report of the 
Company's independent auditors for the fiscal year ended September 30, 1995, 
the Company has been experiencing difficulty generating sufficient cash flows 
to meet its obligations and sustain its operations and, as a result, may not 
be able to meet the monthly principal and interest obligations under the 
MEDIQ Note.  Following the completion of the Proposed Sale, the remaining net 
proceeds therefrom would be available to the Company to fund the monthly 
obligations and a portion of the principal obligations upon maturity, if 
necessary, of the MEDIQ Note.  MEDIQ has pledged the MEDIQ Note as collateral 
for certain of its indebtedness to a third party unaffiliated with MEDIQ or 
the Company.  In the event of default by MEDIQ on such indebtedness, such 
third party would  obtain all of MEDIQ's rights under the MEDIQ Note, 
including the right to the payment of principal and interest as and when due 
in accordance with the terms of the MEDIQ Note.

                                       16
<PAGE>

     The MEDIQ Note also provides for certain events of default, including: 
"The . . . sale of all or substantially all of the assets of [the Company] . 
 . ." In an attempt to preclude the possibility of a dispute as to whether the 
Proposed Sale constitutes the sale of all or substantially all of the assets 
of the Company for purposes of the MEDIQ Note on January 5, 1996, the Company 
sent MEDIQ a letter requesting a waiver of this provision in connection with 
the Proposed Sale. MEDIQ sent the Company a letter, dated  January 15, 1996 in 
which MEDIQ declined to grant such a waiver. Nevertheless, in the event MEDIQ 
attempts to accelerate the MEDIQ Note on this basis upon completion of the 
Proposed Sale, the Company intends to aggressively defend its position in any 
legal proceeding. There can be no assurances that the Company would be able 
to obtain a favorable decision in such a legal proceeding. In the event the 
Company were to receive an adverse decision on this matter, the outstanding 
principal balance on the MEDIQ Note would become immediately due and payable 
in full. In that event, the Company may be required to apply the remainder of 
the net proceeds of the Proposed Sale toward the repayment of the outstanding 
principal of the MEDIQ Note, obtain alternative sources of cash with which to 
satisfy such obligation or obtain from MEDIQ a modification to the MEDIQ 
Note. After the repayment of the revolving credit facility, the remaining net 
proceeds may not be sufficient to repay the entire outstanding principal 
balance of the MEDIQ Note at that time, and the Company may not have 
sufficient cash to repay the outstanding principal balance of the MEDIQ Note. 
 Further, if such an adverse decision were to be rendered after the Company 
has used the proceeds, or any portion thereof, for the expansion of the 
Extended Care Services Division or other purposes, the Company may not have 
sufficient cash to repay the outstanding principal balance of the MEDIQ Note. 
There can be no assurance that any other sources of cash will be available to 
the Company.  In such event, the Company may be unable to fulfill its debt 
obligations and also sustain operations at a level at which the Company could 
continue as a going concern. In addition, in the event the Company needs to 
use the remainder of the proceeds to repay the amounts outstanding under the 
MEDIQ Note, the Company's plans to expand the Extended Care Services Division 
would be extremely restricted, and the Company's results of operations and 
financial condition may be adversely affected.

     As a result of the Company's continued negative operating results and 
reduced collections of accounts receivable from certain government-funded 
payors, as well as other administrative delays by third-party payors, the 
Company has been experiencing difficulty generating sufficient cash flows to 
meet its obligations and sustain its operations.  In an effort to improve 
this situation, the Company is pursuing opportunities to sell its 
freestanding facilities, taking steps to reduce operating expenses, 
attempting to raise additional capital, and working to improve its cash 
flows.  With regard to its efforts to sell its freestanding facilities, the 
Company has sold Oakview Treatment Center and entered into the Agreement, as 
amended, for the Proposed Sale.  To date, however, certain conditions to the 
consummation of the Proposed Sale have not been satisfied and the Company has 
not entered into any definitive agreement to sell its other freestanding 
facility. Accordingly, there can be no assurance that the Company will be 
successful in selling such facilities.  See "Recent Developments."  With 
respect to its efforts to reduce operating expenses, the Company is 
implementing reductions in office lease expense by reducing its leased space 
and reductions in personnel expense by reducing staff of the Extended Care 
Services Division.  In addition, the Company has begun experiencing 
improvement in the collection of accounts receivable. The Company's liquidity 
could also be improved by: (i) the collection of additional outstanding 
receivables; (ii) significant reductions in the operating losses of the 
Company's remaining businesses; (iii) significant additional reductions in 
overhead; and (iv) obtaining additional capital and/or financing sources.  
However, there can be no assurance that any of such events will occur or, if 
they do occur, that the impact on cash flows will be sufficient to enable the 
Company to continue its operations.

                                       17
<PAGE>

In the event that the Company is unable to enhance its liquidity, the Company
may be required to renegotiate the terms of its debt agreements and other
financial obligations, significantly curtail its level of operation or otherwise
significantly reduce operating expenses.

     This report includes forward-looking statements based on management's
current plans and expectations, relating to, among other matters, the
anticipated use of proceeds from the sale of freestanding facilities, the
proposed business activities of the Company, estimates of amounts that are not
yet determinable and the proposed activities of the Company relating to
improving its liquidity.  Such statements involve risks and uncertainties which
may cause actual future activities and results of operations to be materially
different from that suggested in this report, including, among others, risks
associated with industry consolidation and acquisitions, the need to manage
growth, the possible need to use the net cash proceeds from the sale of
freestanding facilities for the retirement of certain indebtedness and
competition.  For additional information, please refer to the Company's Annual
Report on Form 10-K and other reports filed by the Company with the Securities
and Exchange Commission.


                                       18
<PAGE>

PART II. OTHER INFORMATION

Item 6.   Exhibits and Reports on Form 8-K

     (a)  Exhibits:

     10.15     Amendment to Asset Purchase Agreement, dated as of April 11,
               1996, by and among the Registrant, MHM of Ohio, Inc. and
               Behavioral Healthcare Corporation (Filed herewith).


     (b)  Reports on Form 8-K

          A report on Form 8-K dated February 9, 1996 was filed to announce
          that the Registrant had signed a definitive agreement for the sale of
          five of its freestanding facilities.  See Item 2.


                                       19
<PAGE>

                                    SIGNATURE




Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.





Dated:  May 9, 1996                    Mental Health Management, Inc.


                                         /s/ Vicki S. Hammond
                                        ------------------------------
                                        Vicki S. Hammond
                                        Senior Vice President, Finance
                                        and Chief Financial Officer



                                       20

<PAGE>

                      AMENDMENT TO ASSET PURCHASE AGREEMENT

     THIS AMENDMENT TO ASSET PURCHASE AGREEMENT (the "Amendment"), dated as of
April 11, 1996, is by and among MENTAL HEALTH MANAGEMENT, INC., a Delaware
corporation ("MHM"), and MHM OF OHIO, INC., an Ohio corporation ("MHM-Ohio"),
(MHM and MHM-Ohio are referred to herein individually and, as the context
requires, collectively as the "Seller"), and BEHAVIORAL HEALTHCARE CORPORATION,
a Delaware corporation (the "Parent"), individually and on behalf of various
wholly-owned subsidiaries of the Parent (collectively, the "BHC Subs"), (the BHC
Subs and the Parent, collectively and individually when the context so requires,
the "Purchaser").


                                    RECITALS

     WHEREAS, the Seller and the Purchaser are parties to that certain Asset
Purchase Agreement, dated as of January 24, 1996 (the "Agreement"); and

     WHEREAS, the Seller and the Purchaser desire to amend certain provisions of
the Agreement with respect to the receivables of the Hospital Businesses and
certain other matters.

     NOW, THEREFORE, in consideration of the premises and of the mutual
representations, warranties, covenants and agreements of the parties hereinafter
set forth, the parties hereby agree as follows:

     1.   AMENDMENTS TO THE AGREEMENT.  The Agreement is hereby amended as
follows:

          (a)  Section 1.1 of the Agreement is hereby deleted in its entirety
and replaced with the following:

          1.1. SALE OF ASSETS. At the Closing (as hereinafter defined), the
     Seller shall sell, transfer, convey, assign and deliver to the Purchaser,
     and the Purchaser shall purchase from the Seller, the following assets and
     properties:

               (a)  all real property or leasehold interests in real property
     used in connection with the operation of the Hospital Businesses, as
     described in SCHEDULE 1.1(a), together with all buildings, improvements and
     fixtures located thereupon and all construction in progress (the "Real
     Property"), such Schedule to include a metes and bounds description for
     each such parcel of Real Property owned by the Seller;

<PAGE>

               (b)  all tangible personal property (excluding cash) owned by the
     Seller and used in connection with the Hospital Businesses (but excluding
     any such property not located at the Hospitals unless such equipment is
     necessary for operation of the Hospital Businesses), including, without
     limitation, all equipment, furniture, fixtures, machinery, vehicles, office
     furnishings, instruments, leasehold improvements, spare parts, and, to the
     extent assignable or transferable by the Seller, all rights in all
     warranties of any manufacturer or vendor with respect thereto (the
     "Personal Property"), which Personal Property is more specifically
     described in SCHEDULE 1.1(b);

               (c)  all rights, to the extent assignable or transferable, to all
     licenses, certificates of need, certificates of exemption, franchises,
     accreditations and registrations and other licenses or permits issued in
     connection with the Hospital Businesses (the "Licenses"), including,
     without limitation, the Licenses described in SCHEDULE 1.1(c);

               (d)  all of its interest, to the extent assignable or
     transferable by it, in and to those real property and personal property
     leases relating to the Hospital Businesses described in SCHEDULE 1.1(d)
     (collectively, the "Leases");

               (e)  all of its interest, to the extent assignable or
     transferable by it, in and to those contracts and agreements (including,
     without limitation, purchase orders) relating to the Hospital Businesses
     set forth in SCHEDULE 1.1(e) (the "Contracts");

               (f)  any deposits, escrows, prepaid taxes or other advance
     payments relating to any expenses of the Hospital Businesses described in
     SCHEDULE 1.1(f) (the "Prepaid Expenses");

               (g)  all inventories of supplies, drugs, food, janitorial and
     office supplies and other disposables and consumables existing on the
     Closing Date (as hereinafter defined) and located at the Hospitals or
     purchased by Seller for use in connection with the Hospital Businesses
     described in SCHEDULE 1.1(g) (the "Inventory");

               (h)  all documents, records, operating manuals and files, and
     computer software owned by Seller or its affiliates, pertaining to or used
     in connection with the Hospital Businesses (the "Software"), including,
     without limitation, all patient records (but only to the extent

                                        2

<PAGE>

     transferable), medical records (but only to the extent transferable),
     financial records, equipment records, construction plans and
     specifications, and medical and administrative libraries, but excluding
     Seller's corporate record books, minute books and tax records and any
     Software not located at the Hospitals unless it is necessary for the
     operation of the Hospital Businesses;

               (i)  all of its rights, if any, to the names and symbols used in
     connection with the Hospital Businesses other than the name of Seller;

               (j)  all insurance proceeds arising in connection with damage to
     the Assets (as hereinafter defined) occurring after December 31, 1995 and
     prior to the Closing to the extent not expended on the repair or
     restoration of such Assets; and

               (k)  except as expressly excluded below, all other property owned
     by the Seller, whether tangible or intangible, located at the Hospitals or
     necessary for the operation of the Hospital Businesses whether or not
     reflected on the balance sheet of the Seller (including, without
     limitation, any claims, other than those presently being pursued by the
     Seller, against third parties by the Seller relating to the Assets whether
     known or unknown, contingent or otherwise).

          The foregoing, which (except for the Excluded Assets, as hereinafter
     defined) are hereafter referred to, collectively, as the "Assets", comprise
     substantially all of the property and assets (other than accounts
     receivable) used in the conduct and operation of the Hospital Businesses as
     of the date of this Agreement, including, without limitation, those assets
     of the Hospital Businesses reflected on the Seller's balance sheet dated as
     of December 31, 1995 (the "December 31, 1995 Balance Sheet"), and will
     include all assets located at the Hospitals or necessary for the operation
     of the Hospital Businesses and acquired by the Seller between December 31,
     1995 and the Closing.

          (b)  Section 1.2 of the Agreement is hereby deleted in its entirety
and replaced with the following:

          Section 1.2.  EXCLUDED ASSETS. The following assets, which are or
     might be considered to be related to the Assets, are not intended by the
     parties to be a  part of the sale and purchase contemplated hereunder and
     are excluded from the Assets (collectively, the "Excluded Assets"): (i) all
     cash and cash equivalents; (ii) all

                                        3

<PAGE>

     accounts receivable, including, without limitation, cost-based and non-
     cost-based accounts receivable, of the Hospital Businesses (the
     "Receivables"); (iii) except as otherwise set forth in Section 10.2,
     assets, claims and other rights, including, without limitation, any
     reimbursement from Medicare or Medicaid as a result of the loss by the
     Seller on the disposal of the Assets for purposes of Medicare and Medicaid
     reimbursement for all periods ended on or prior to the Closing Date,
     including the terminating cost reports (the "Special Loss Reimbursement");
     (iv) assets (including, without limitation, real property) necessary for
     the operation of Oak View Treatment Center, Mountain Crest Hospital and
     Mountain Crest Behavioral Healthcare System; (v) all rights and privileges
     under contracts, agreements and leases listed on SCHEDULE 1.2(a); (vi) all
     supplies, drugs, food and other disposables and consumables disposed of in
     the ordinary course of business prior to the Closing; and (vii) all
     documents, records and operating manuals pertaining to the Hospital
     Businesses deemed proprietary to the Seller and described in SECTION 5.4 or
     which the Seller is required by law to retain.

          (c)  Section 1.4 of the Agreement is hereby deleted in its entirety
and replaced with the following:

          Section 1.4.  PURCHASE PRICE: VALUE OF CERTAIN ASSETS. (a) The
     purchase price of the Assets (the "Purchase Price") shall be:

             (i)    cash, certified or cashier's check, wire transfer or other
                    immediately available funds in the amount of $10,000,000;
                    PLUS

            (ii)    the Value of the Inventory (as defined below); PLUS

           (iii)    the Value of the Prepaid Expenses (as defined below); LESS

            (iv)    an amount equal to the Seller's liabilities for accrued
                    "Paid Days Off" ("PDO") and any other vested benefits set
                    forth on SCHEDULE 1.4 (vi) due to the Hired Employees (as
                    defined in Section 5.4); LESS

             (v)    the Value of the Other Current Liabilities, Accounts
                    Payable, Salaries

                                        4

<PAGE>

                    Payable and Payroll Taxes Payable (as hereinafter defined).

          (b)  As used herein, the term "Value of the Inventory" shall mean the
     aggregate book value of the Hospitals' Inventory as of the Closing Date, as
     initially determined at the Closing by using the amounts set forth on the
     Interim Balance Sheet (as hereinafter defined) and as finally determined by
     using the amounts set forth on the Closing Balance Sheet (as hereinafter
     defined).

          (c)  As used herein, the term "Value of the Prepaid Expenses" shall
     mean the sum of (i) aggregate book value of the Hospitals' Prepaid Expenses
     as of the Closing Date, as initially determined at the Closing by using the
     amounts set forth on the Interim Balance Sheet (as hereinafter defined) and
     as finally determined by using the amounts set forth on the Closing Balance
     Sheet; and (ii) $36,798, which is the amount expended by Seller to have a
     new fire alarm system installed at the request of Purchaser at Pacific
     Shores Hospital.

          (d)  As used herein, the term "Value of the Other Current Liabilities,
     Accounts Payable, Salaries Payable and Payroll Taxes Payable" shall mean
     the aggregate book value of the Hospital's Other Current Liabilities,
     Accounts Payable, Salaries Payable and Payroll Taxes Payable, excluding
     therefrom liabilities for (i) accrued pension expenses, (ii) amounts
     accrued under the Seller's Employee Stock Purchase Plan or similar benefit
     plans and (iii) amounts prorated at the Closing pursuant to Section 1.8 as
     of the Closing Date. Such amount shall initially be determined at the
     Closing by using the amounts set forth in the Interim Balance Sheet and
     finally determined by using the amounts set forth on the Closing Balance
     Sheet.

          (e)  Pursuant to the terms of an Escrow Agreement to be agreed upon
     by the parties, the Purchaser shall escrow a portion of the Purchase Price
     (not to exceed $300,000) until the Purchaser is satisfied in its reasonable
     discretion of the satisfactory completion of the work at Windsor Hospital
     and Pinon Hills Residential Treatment Center more fully described in
     Exhibit A attached hereto; provided, however, that the Escrow Agreement
     shall allow disbursement of funds to make progress or final payments to
     contractors carrying out such work and the Escrow Agreement shall reflect
     the principles described in Exhibit A.

                                        5

<PAGE>

          (d)  Section 1.5 of the Agreement is hereby amended by changing the
     date "April 30, 1996" to "May 31, 1996."

          (e)  Section 1.7(b) of the Agreement is hereby deleted in its entirety
     and replaced with the following:

          Section 1.7.  ADJUSTMENTS TO PURCHASE PRICE.

               (b)  Subject to the provisions of Section 1.7(d) below, within
     ninety (90) days after the Closing Date (or as soon thereafter as
     possible), the parties shall make final adjustments to the Purchase Price
     (the "Post Closing Adjustments"). The Seller shall furnish to the
     Purchaser, within forty-five (45) days after the Closing, a balance sheet
     of the Seller with respect to the Hospital Businesses as of the close of
     business on the Closing Date (the "Closing Balance Sheet"). The Closing
     Balance Sheet will be used to determine any final adjustments to the
     Purchase Price relating to (i) the Purchaser's assumption of the Seller's
     liabilities, and (ii) prorations contemplated hereby.

          (f)  Section 4.4 of the Agreement is hereby deleted in its entirety
and replaced with the following:

          Section 4.4  TITLE COMMITMENTS AND SURVEYS. The Seller will, prior to
     the Closing, deliver to Purchaser the Title Commitments for owner's title
     insurance from the Seller's issuing agents of Lawyer's Title (collectively,
     the "Title Company"). Additionally, the Seller will, prior to the Closing,
     deliver to the Purchaser ALTA/ACSM as-built surveys of the Real Property
     (the "Surveys") showing the perimeter boundaries of the Real Property and
     all improvements thereon. Notwithstanding the foregoing sentence, the
     Survey relating to the Real Property at Windsor Hospital shall be a
     recertification of a survey prepared August 4, 1986 (the "1986 Survey"), as
     recertified on April 10, 1991, as recertified on March 28, 1995. The 1986
     Survey was prepared to accuracy standards in effect on August 4, 1986,
     which is an accurate field survey. The Title Commitments are, and at the
     Closing the Surveys will be, set forth on SCHEDULE 2.7.

          (g)  The following sentence is hereby added to the end of Section 5.2
of the Agreement:

          Upon the Seller's written request, the Purchaser will, at the expense
     of the Seller based on the Purchaser's actual copying and labor costs,
     provide to the Seller and its representatives (including, without

                                        6

 
<PAGE>

     limitation, its attorneys and accountants) copies of the records
     transferred to the Purchaser at the Closing (including, without limitation,
     records of patients treated by the Seller at the Hospitals) after the
     Closing Date.

          (h)  Section 7.4 of the Agreement is hereby deleted in its entirety
and replaced with the following:

          Section 7.4.  CONSENTS, APPROVALS AND LICENSES. The Purchaser shall
     have received and been issued (either on a contingent or permanent basis)
     all licenses and approvals (except for Controlled Substance Registration
     Certificates) required under the provisions of state and federal law
     necessary for the Purchaser to legally conduct all relevant operations of
     the Hospitals being conducted by the Seller on the Closing Date, and the
     Purchaser or the Seller shall have obtained all non-governmental third
     party consents reasonably necessary for the legal and authorized transfer
     of all material Assets, including, without limitation, (i) the Scheduled
     Contracts and Scheduled Leases, (ii) consent to the assignment of the lease
     for Aspen Hill Hospital, (iii) the release by Copelco Capital, Inc. of its
     liens on the Seller's property, and (iv) the release by Congress Financial
     Corporation of its liens to the extent that such liens encumber the Assets.

          (g)  Section 8.2 of the Agreement is hereby amended by changing the
date "April 30, 1996" to "May 31, 1996."

          (h)  Section 10.2 of the Agreement is hereby deleted in its entirety
and replaced with the following:

          Section 10.2.  MEDICARE AND MEDICAID, ETC. RECEIVABLES AND PAYABLES.
     (a) With respect to Medicare, Medicaid, CHAMPUS, and cost-based Blue Cross
     cost reports for periods beginning after the Effective Time (as defined in
     Section 11.4), the Purchaser and the Seller agree that the Purchaser shall
     be (i) responsible for filing Medicare, Medicaid, CHAMPUS, and cost-based
     Blue Cross provider cost reports or forms associated with said periods for
     the Hospitals, (ii) entitled to any receivables relating to said cost
     reports, and (iii) responsible for any liabilities relating to said cost
     reports.

          (b)  With respect to Medicare, Medicaid, CHAMPUS, and cost-based Blue
     Cross cost reports for periods ending prior to the Effective Time, the
     Purchaser and the Seller agree that the Seller shall be (i) responsible for
     filing

                                        7

<PAGE>

     Medicare, Medicaid, CHAMPUS, and cost-based Blue Cross provider cost
     reports or forms associated with said periods for the Hospital, (ii)
     entitled to any receivables relating to said cost reports, and (iii)
     responsible for any liabilities relating to said cost reports.

          (c)  With respect to Medicare, Medicaid, CHAMPUS, and cost-based Blue
     Cross terminating cost reports due as a result of the transactions
     contemplated herein, the Purchaser and the Seller agree that the Seller
     shall be responsible for filing, subsequent to the Purchaser's review of
     such filing, provider cost reports or forms associated with said
     terminating periods for the Hospitals, and the Seller shall be entitled to
     any receivables relating to said cost reports (except for any Special Loss
     Reimbursement as set forth below) and be responsible for any liabilities
     relating to said cost reports. The Purchaser and the Seller agree that the
     Seller and the Purchaser shall be entitled to eighty-five percent (85%) and
     fifteen percent (15%), respectively, of the aggregate Special Loss
     Reimbursement contained on the terminating cost reports for the Hospitals.
     This provision shall apply regardless of whether the new settlement on a
     given cost report is a receivable or a liability. For example, if a given
     cost report is settled with a liability of $50,000 owing to the Medicare
     Program, and includes a Special Loss Reimbursement in the amount of
     $100,000 due the provider, the Seller would remit $15,000 of the Special
     Loss Reimbursement to the Purchaser, even though the cost report settlement
     in total is a $50,000 amount due the Medicare Program, which amount shall
     be paid by Seller.

          (d)  The Purchaser agrees that it shall not file or cause to be filed
     any amended cost reports in the Seller's name for periods ending prior to
     the Effective Time, for any reason, without the prior written consent of
     the Seller, the Seller having sole discretion as to the filing of said
     amended cost reports. With regard to cost reports which have been audited
     and/or settled, the Purchaser agrees that it shall not request a reopening
     of, or otherwise cause a reopening of any cost reports which have been
     settled for periods ending prior to the Effective Time, for any reason,
     without the prior written consent of the Seller, the Seller having sole
     discretion as to any provider-initiated reopenings of said settled cost
     reports. With regard to cost reports which have been filed, but not audited
     and/or not settled for periods ending prior to the Effective Time, the
     Purchaser agrees that it shall not negotiate the settlement of said

                                        8

<PAGE>

     cost reports without the prior written consent of the Seller. Additionally,
     the Purchaser agrees to notify the Seller immediately upon receiving
     notification of any settlement or audit action (e.g., notification of desk
     audit, field audit, proposed audit adjustments, issuance of a notice of
     intent to reopen, or issuance of a Notice of Program Reimbursement) to be
     taken by a fiscal intermediary with regard to unaudited and/or unsettled
     cost reports for periods ending prior to the Effective Time, and the
     Purchaser shall not file or cause to be filed any amended cost reports in
     the Seller's name for the terminating cost reporting period, in respect of
     any home office and intercompany transaction group appeals, without the
     prior written consent of the Seller, the Seller having sole discretion as
     to the filing of such amended cost reports.

          (e)  Following the Closing, the parties shall cooperate with each
     other and, except as limited by Section 10.2(a) above, shall make available
     to each other, as reasonably requested, and to any Medicare/Medicaid,
     CHAMPUS or cost-based Blue Cross authority, all information, records or
     documents relating to the Medicare, Medicaid, CHAMPUS and cost-based Blue 
     Cross receivables and payables of the Hospitals and shall preserve all such
     information, records and documents until the expiration of any applicable 
     statute of limitations or extensions thereof. The parties shall also make 
     available to each other as is reasonably required, and at the cost of the 
     requesting party, personnel responsible for preparing or maintaining 
     information, records and documents in connection with such matters.

          (f)  Any funds received by the Seller, on the one hand, or the
     Purchaser, on the other hand, due to the other under this Agreement shall
     be paid to such party within two (2) days after receipt thereof. Any
     liabilities associated with cost reports for periods ending prior to the
     Effective Time, including, without limitation, the terminating cost report,
     must be paid by the Seller no later than the date required by the fiscal
     intermediary.

          (g)  The Seller and the Purchaser agree that the values determined as
     set forth on SCHEDULE 1.6 represent fair market values of the Assets and
     that these same values will be used for Medicare, Medicaid, CHAMPUS and
     cost-based Blue Cross cost reporting purposes.

                                        9

<PAGE>

          (h)  The parties represent to each other that the transactions set
     forth herein reflect an arm's length transaction between the Seller and the
     Purchaser, that neither party to a significant extent is associated or
     affiliated with, or has control of, or is controlled by, the other party,
     and, as a result, the parties intend that on and after the date hereof the
     Purchaser shall not be deemed to be a "related party" to the Seller under
     the Medicare and Medicaid regulations.

     2.   CAPITALIZED TERMS: CROSS-REFERENCES. All capitalized terms used herein
shall have the same meaning as when used in the Agreement. Cross-references,
unless otherwise indicated, are to the Agreement.

     3.   EFFECT OF AMENDMENT. As hereby amended, the Agreement shall remain in
full force and effect.

     IN WITNESS WHEREOF, the parties hereto have duly executed this Amendment as
of the day and year first above written.

                                   MENTAL HEALTH MANAGEMENT, INC.


                                   By: /s/Michael S. Pinkert
                                       ---------------------------------------
                                       Michael S. Pinkert,
                                       President and Chief Executive Officer


                                   MHM OF OHIO, INC.


                                   By: /s/Michael S. Pinkert
                                       ---------------------------------------
                                       Michael S. Pinkert,
                                       President and Chief Executive Officer


                                   PARENT

                                   BEHAVIORAL HEALTHCARE CORPORATION


                                   By: /s/ Michael E. Davis
                                       ---------------------------------------
                                       Michael E. Davis,
                                       Chief Financial Officer


                                       10

 
<PAGE>

                                    EXHIBIT A


     WORK AT WINDSOR HOSPITAL ("WINDSOR").  The work to be carried out at
Windsor is described in the memorandum from Bruce Waldo to Mike Pinkert, dated
April 5, 1996.  The work needed regarding asbestos is described on the page
entitled "PSI Findings" and "Sample FHA 29" is encompassed in the first
description on that page (i.e., the reference to "721 square feet of asbestos").
Removal of asbestos may not be required in every case; encapsulation may be
appropriate in one or more areas.

     WORK AT PINON HILLS RESIDENTIAL TREATMENT CENTER ("PINON").  Construction
work to enclose two porches and thereby increase the physical capacity to the
full number of licensed beds (53) will be completed.  In addition, the Seller
will be responsible for the engineering costs of planning and designing, and the
construction costs of constructing, a new sewage system capable of handling
5,000 gallons per day.  (Any additional costs arising from the planning, design,
and construction of a system capable of handling 7,000 gallons per day shall be
at the expense of the Purchaser, not the Seller).

     The Escrow Agreement will include the following terms:

     (1)  No more than $150,000 will be allocated for the work at Windsor and no
more than $150,000 will be allocated for the work at Pinon.

     (2)  Any amounts paid by the Seller for the work at either Windsor or Pinon
prior to Closing will reduce, dollar-for-dollar, the amount put in escrow at
Closing for the work at Windsor or Pinon, as the case may be.

     (3)  The funds in escrow may be used to make payment after Closing for the
work.

     (4)  Any contract not entered into prior to Closing that is needed to
complete any work described herein shall be entered into by the Purchaser after
the Purchaser obtains the Seller's approval, which approval shall not be
unreasonably withheld or delayed.

     (5)  If, at any time in the reasonable determination of the Purchaser and
the Seller, the funds in escrow are insufficient to pay for work described
herein, then the Seller shall promptly deposit an agreed upon amount of funds
into the escrow account.

     (6)  Upon satisfactory completion of all of the work at Windsor or Pinon,
any unspent amounts in escrow allocated for the work at such facility shall be
promptly paid to the Seller.


                                       A-1
<PAGE>

     (7)  The amount allocated to the escrow will bear interest at the rate of
interest customarily paid upon escrowed funds by the escrow agent.

     Satisfactory completion of the work described above shall be deemed to
satisfy any objections that Purchaser has with respect to the physical and
environmental condition of the Hospitals resulting from the Seller's disclosures
to the Purchaser or the engineering and environmental studies conducted on
behalf of the Purchaser.


                                       A-2


<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          SEP-30-1996
<PERIOD-END>                               MAR-31-1996
<CASH>                                       1,116,000
<SECURITIES>                                         0
<RECEIVABLES>                                9,641,000
<ALLOWANCES>                                 2,025,000
<INVENTORY>                                     94,000
<CURRENT-ASSETS>                             9,588,000
<PP&E>                                      16,828,000
<DEPRECIATION>                               6,060,000
<TOTAL-ASSETS>                              25,234,000
<CURRENT-LIABILITIES>                        9,261,000
<BONDS>                                              0
                                0
                                          0
<COMMON>                                        33,000
<OTHER-SE>                                   3,265,000
<TOTAL-LIABILITY-AND-EQUITY>                25,234,000
<SALES>                                              0
<TOTAL-REVENUES>                            22,502,000
<CGS>                                                0
<TOTAL-COSTS>                               15,919,000
<OTHER-EXPENSES>                            10,643,000
<LOSS-PROVISION>                             2,846,000
<INTEREST-EXPENSE>                             766,000
<INCOME-PRETAX>                            (7,672,000)
<INCOME-TAX>                                 (175,000)
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (7,497,000)
<EPS-PRIMARY>                                   (2.27)
<EPS-DILUTED>                                        0
        

</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission